Loading...
•
Dec 31, 2025
Enovis Q4 2025 Earnings Report
Enovis Q4 2025 Earnings Report
Key Takeaways
Enovis reported a challenging fourth quarter with a significant net loss due to a $501 million non-cash goodwill impairment charge, despite achieving 3% reported sales growth. The company saw continued momentum in its Reconstructive segment while the Prevention & Recovery segment remained stable, and management highlighted positive free cash flow and debt reduction for the full year.
Fourth quarter net sales grew 3% on a reported basis to $576 million, driven by 7% growth in the Reconstructive segment.
The company recorded a massive $519 million net loss from continuing operations, primarily due to a $501 million non-cash goodwill impairment charge.
Adjusted EBITDA for the quarter was $112 million, with an adjusted EBITDA margin of 19.4%.
Full year 2025 organic sales growth reached 6%, with the Reconstructive segment leading at 8% organic growth.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Enovis expects continued growth in 2026 with revenue reaching up to $2.37 billion and improved adjusted earnings.
Positive Outlook
- Expected revenue range of $2.31 billion to $2.37 billion.
- Anticipated organic revenue growth of 4-6%.
- Adjusted EBITDA expected to rise to $425-435 million.
- Full-year adjusted EPS guidance of $3.52 to $3.73.
- Focus on driving commercial execution and a rich innovation pipeline.
Challenges Ahead
- Ongoing integration risks related to the Lima acquisition.
- Potential disruptions from escalating geopolitical tensions.
- Macroeconomic pressures including inflation.
- Supply chain disruptions and increasing energy costs in Europe.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...